Dietary flavonoid and proanthocyanidin intakes and prostate cancer risk in a prospective cohort of US men

American Journal of Epidemiology

Volumn 179, Issue 8, 2014, Pages 974-986

  Wang, Ying ^a   Stevens, Victoria L ^b   Shah, Roma ^b   Peterson, Julia J ^b   Dwyer, Johanna T ^b   Gapstur, Susan M ^b   Mccullough, Marjorie L ^b  

^a AMERICAN CANCER SOCIETY   (United States)

^b NONE

Author keywords

flavonoids; proanthocyanidins; prospective cohort study; prostate cancer

Indexed keywords

FLAVAN DERIVATIVE; FLAVANONE DERIVATIVE; FLAVONE DERIVATIVE; FLAVONOID; FLAVONOL DERIVATIVE; ISOFLAVONE DERIVATIVE; PROANTHOCYANIDIN;

BIOLOGICAL UPTAKE; CANCER; COHORT ANALYSIS; DIET; EPIDEMIOLOGY; MALE; MEDICINE; PIGMENT; QUESTIONNAIRE SURVEY; REGRESSION ANALYSIS; RISK FACTOR; SECONDARY METABOLITE; SPATIOTEMPORAL ANALYSIS;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BANANA; CANCER GRADING; CANCER PREVENTION; CANCER RISK; CLINICAL TRIAL; DIETARY INTAKE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PROSPECTIVE STUDY; PROSTATE CANCER; QUESTIONNAIRE; TUMOR GROWTH; VERY ELDERLY;

UNITED STATES;

FLAVONOIDS; PROANTHOCYANIDINS; PROSPECTIVE COHORT STUDY; PROSTATE CANCER;

AGED; ANTIOXIDANTS; DIET; DIET SURVEYS; FLAVONOIDS; FOLLOW-UP STUDIES; HEALTH BEHAVIOR; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROANTHOCYANIDINS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUESTIONNAIRES; RISK; RISK FACTORS; UNITED STATES;

EID: 84897472459     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwu006     Document Type: Article

References (51)

1. Hsing AW, Chokkalingam AP. Prostate cancer epidemiology. Front Biosci. 2006;11:1388-1413
2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11-30
3. Whittemore AS, Kolonel LN, Wu AH, et al. Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst. 1995;87(9):652-661
4. Le Marchand L, Kolonel LN, Wilkens LR, et al. Animal fat consumption and prostate cancer: A prospective study in Hawaii. Epidemiology. 1994;5(3):276-282
5. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research; 2007
6. Kushi LH, Doyle C, McCullough M, et al. American Cancer Society guidelines on nutrition and physical activity for cancer prevention: Reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin. 2012;62(1): 30-67
7. Le Marchand L. Cancer preventive effects of flavonoids - A review. Biomed Pharmacother. 2002;56(6):296-301
8. Nandakumar V, Singh T, Katiyar SK. Multi-targeted prevention and therapy of cancer by proanthocyanidins. Cancer Lett. 2008; 269(2):378-387
9. Neuhouser ML. Dietary flavonoids and cancer risk: Evidence from human population studies. Nutr Cancer. 2004;50(1): 1-7
10. Romagnolo DF, Selmin OI. Flavonoids and cancer prevention: A review of the evidence. J Nutr Gerontol Geriatr. 2012;31(3): 206-238
11. Hedelin M, Klint A, Chang ET, et al. Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: The Cancer Prostate Sweden Study (Sweden). Cancer Causes Control. 2006;17(2):169-180
12. Hirvonen T, Virtamo J, Korhonen P, et al. Flavonol and flavone intake and the risk of cancer in male smokers (Finland). Cancer Causes Control. 2001;12(9):789-796
13. Knekt P, Kumpulainen J, Järvinen R, et al. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr. 2002;76(3):560-568
14. Lee MM, Gomez SL, Chang JS, et al. Soy and isoflavone consumption in relation to prostate cancer risk in China. Cancer Epidemiol Biomarkers Prev. 2003;12(7):665-668
15. McCann SE, Ambrosone CB, Moysich KB, et al. Intakes of selected nutrients, foods, and phytochemicals and prostate cancer risk in western New York. Nutr Cancer. 2005;53(1): 33-41
16. Park SY, Murphy SP, Wilkens LR, et al. Legume and isoflavone intake and prostate cancer risk: The Multiethnic Cohort Study. Int J Cancer. 2008;123(4):927-932
17. Bosetti C, Bravi F, Talamini R, et al. Flavonoids and prostate cancer risk: A study in Italy. Nutr Cancer. 2006;56(2):123-127
18. Geybels MS, Verhage BA, Arts IC, et al. Dietary flavonoid intake, black tea consumption, and risk of overall and advanced stage prostate cancer. Am J Epidemiol. 2013;177(12):1388-1398
19. United States Department of Agriculture. USDA Database for the Proanthocyanidin Content of Selected Foods. Beltsville, MD: Agricultural Research Service, Nutrient Data Laboratory; 2004
20. Bhagwat S, Haytowitz DB, Holden JM. USDA Database for the Flavonoid Content of Selected Foods, Release 3.1. Beltsville, MD: Agricultural Research Service, Nutrient Data Laboratory; 2013
21. Calle EE, Rodriguez C, Jacobs EJ, et al. The American Cancer Society Cancer Prevention Study II Nutrition Cohort: Rationale, study design, and baseline characteristics. Cancer. 2002;94(9): 2490-2501
22. Garfinkel L. Selection, follow-up, and analysis in the American Cancer Society prospective studies. Natl Cancer Inst Monogr. 1985;67:49-52
23. American Cancer Society. Study questionnaires. http://www. cancer.org/research/researchprogramsfunding/epidemiologycancerpreventionstudies/ studyquestionnaires/index. Accessed March 11, 2013
24. United States Department of Agriculture. USDA Database for the Flavonoid Content of Selected Foods, Release 2.1 Beltsville, MD: Agricultural Research Service, Nutrient Data Laboratory; 2007
25. United States Department of Agriculture. Iowa State University Database on the Isoflavone Content of Foods, Release 1.4 Beltsville, MD: Agricultural Research Service, Nutrient Data Laboratory; 2007
26. Peterson JJ, Beecher GR, Bhagwat SA, et al. Flavanones in grapefruit, lemons, and limes: A compilation and review of the data from the analytical literature. J Food Compost Anal. 2006; 19(suppl):S74-S80
27. Peterson JJ, Dwyer JT, Beecher GR, et al. Flavanones in oranges, tangerines (mandarins), tangors, and tangelos: A compilation and review of the data from the analytical literature. J Food Compost Anal. 2006;19(suppl):S66-S73
28. Peterson J, Dwyer J, Bhagwat S, et al. Major flavonoids in dry tea. J Food Compost Anal. 2005;18(6):487-501
29. Bobe G, Peterson JJ, Gridley G, et al. Flavonoid consumption and esophageal cancer among black and white men in the United States. Int J Cancer. 2009;125(5):1147-1154
30. Calle EE, Terrell DD. Utility of the National Death Index for ascertainment of mortality among cancer prevention study II participants. Am J Epidemiol. 1993;137(2):235-241
31. American Joint Committee on Cancer. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010
32. Willett W, Stampfer MJ. Total energy intake: Implications for epidemiologic analyses. Am J Epidemiol. 1986;124(1):17-27
33. Rodriguez C, Patel AV, Mondul AM, et al. Diabetes and risk of prostate cancer in a prospective cohort of US men. Am J Epidemiol. 2005;161(2):147-152
34. Kleinbaum DG, Kupper LL, Nizam A, et al. Applied Regression Analysis and Other Multivariable Methods. 4th ed. Belmont, CA: Duxbury; 2008
35. Rodriguez C, Freedland SJ, Deka A, et al. Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev. 2007;16(1):63-69
36. Routh JC, Leibovich BC. Adenocarcinoma of the prostate: Epidemiological trends, screening, diagnosis, and surgical management of localized disease. Mayo Clin Proc. 2005;80(7): 899-907
37. Platz EA, De Marzo AM, Giovannucci E. Prostate cancer association studies: Pitfalls and solutions to cancer misclassification in the PSA era. J Cell Biochem. 2004;91(3): 553-571
38. Holzbeierlein JM, McIntosh J, Thrasher JB. The role of soy phytoestrogens in prostate cancer. Curr Opin Urol. 2005;15(1): 17-22
39. Yan L, Spitznagel EL. Soy consumption and prostate cancer risk in men: A revisit of a meta-analysis. Am J Clin Nutr. 2009; 89(4):1155-1163
40. Nagata Y, Sonoda T, Mori M, et al. Dietary isoflavones may protect against prostate cancer in Japanese men. J Nutr. 2007; 137(8):1974-1979
41. Kurahashi N, Iwasaki M, Sasazuki S, et al. Soy product and isoflavone consumption in relation to prostate cancer in Japanese men. Cancer Epidemiol Biomarkers Prev. 2007; 16(3):538-545
42. Rossi M, Bosetti C, Negri E, et al. Flavonoids, proanthocyanidins, and cancer risk: A network of case-control studies from Italy. Nutr Cancer. 2010;62(7):871-877
43. Rossi M, Rosato V, Bosetti C, et al. Flavonoids, proanthocyanidins, and the risk of stomach cancer. Cancer Causes Control. 2010;21(10):1597-1604
44. Plumb GW, De Pascual-Teresa S, Santos-Buelga C, et al. Antioxidant properties of catechins and proanthocyanidins: Effect of polymerisation, galloylation and glycosylation. Free Radic Res. 1998;29(4):351-358
45. Brasky TM, Kristal AR, Navarro SL, et al. Specialty supplements and prostate cancer risk in the VITamins and Lifestyle (VITAL) cohort. Nutr Cancer. 2011;63(4): 573-582
46. Song WO, Chun OK. Tea is the major source of flavan-3-ol and flavonol in the U.S. diet. J Nutr. 2008;138(8): 1543S-1547S
47. Wang Y, Chung SJ, Song WO, et al. Estimation of daily proanthocyanidin intake and major food sources in the U.S. diet. J Nutr. 2011;141(3):447-452
48. Kurahashi N, Sasazuki S, Iwasaki M, et al. Green tea consumption and prostate cancer risk in Japanese men: A prospective study. Am J Epidemiol. 2008;167(1):71-77
49. Rimm EB, Giovannucci EL, Stampfer MJ, et al. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol. 1992;135(10): 1114-1126
50. Salvini S, Hunter DJ, Sampson L, et al. Food-based validation of a dietary questionnaire: The effects of week-to-week variation in food consumption. Int J Epidemiol. 1989;18(4): 858-867
51. McCullough ML, Peterson JJ, Patel R, et al. Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults. Am J Clin Nutr. 2012;95(2): 454-464.